LIVIVO - Search results -

Search results

Result 1 - 10 of total 126

Search options

Article ; Online: PrEP for Transgender People: A Systematic review.

Perez-Alba, Eduardo / Iquize-Condori, Roxana Claudia / Cantú-Hernández, Jorge Alberto / Álvarez-Villalobos, Neri Alejandro / Salinas-García, Luis Adrián / Camacho-Ortiz, Adrián

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

2024

Language	English
Publishing date	2024-04-24
Publishing country	United States
Document type	Journal Article
ZDB-ID	1099781-7
ISSN	1537-6591 ; 1058-4838
ISSN (online)	1537-6591
ISSN	1058-4838
DOI	10.1093/cid/ciae226
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1505: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 480: Show issues

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Planktonic and biofilm states of Staphylococcus aureus isolated from bone and joint infections and the in vitro effect of orally available antibiotics.

Perez-Alba, Eduardo / Flores-Treviño, Samantha / Villarreal-Salazar, Verónica / Bocanegra-Ibarias, Paola / Vilchez-Cavazos, Félix / Camacho-Ortiz, Adrián

Journal of applied microbiology

2023 Volume 134, Issue 12

Abstract: Aims: To demonstrate the in vitro activity of orally available antibiotics against Staphylococcus aureus isolated from bone or orthopedic implant materials. The biofilm eradication of the combination of three antibiotics was also assessed.: Methods ... ...

Abstract	Aims: To demonstrate the in vitro activity of orally available antibiotics against Staphylococcus aureus isolated from bone or orthopedic implant materials. The biofilm eradication of the combination of three antibiotics was also assessed. Methods and results: Clinical isolates from orthopedic infection samples were collected, and S. aureus isolates were classified according to their biofilm production and composition. Almost all S. aureus isolates (n = 36, 97.3%) produced biofilm and the major biofilm components were polysaccharides. Antimicrobial susceptibility was determined in planktonic (minimal inhibitory concentration; MIC) and biofilm cells (minimal biofilm eradication concentration; MBEC) using the MBEC Calgary Device. Overall, the MBEC ranged higher than the MIC. When combined at borderline-susceptible concentrations, moxifloxacin-rifampin and doxycycline-rifampin were both able to eradicate biofilms in a third of the strains whereas the doxycycline-moxifloxacin combination proved ineffective at eradicating biofilm, inhibiting it only in three strains. Conclusions: We propose rifampin in combination with moxifloxacin or doxycycline for the design of clinical trials of bone and/or orthopedic device infection without proper debridement or material retention.
MeSH term(s)	Humans ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Staphylococcus aureus ; Rifampin/pharmacology ; Moxifloxacin/pharmacology ; Moxifloxacin/therapeutic use ; Doxycycline/pharmacology ; Plankton ; Staphylococcal Infections/drug therapy ; Biofilms ; Microbial Sensitivity Tests
Chemical Substances	Anti-Bacterial Agents ; Rifampin (VJT6J7R4TR) ; Moxifloxacin (U188XYD42P) ; Doxycycline (N12000U13O)
Language	English
Publishing date	2023-11-18
Publishing country	England
Document type	Journal Article
ZDB-ID	1358023-1
ISSN	1365-2672 ; 1364-5072
ISSN (online)	1365-2672
ISSN	1364-5072
DOI	10.1093/jambio/lxad258
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 259: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas?

Cerda-Contreras, Christopher / Nuzzolo-Shihadeh, Laura / Camacho-Ortiz, Adrián / Perez-Alba, Eduardo

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

2021 Volume 73, Issue 11, Page(s) e3977–e3978

MeSH term(s)	Azetidines ; COVID-19/drug therapy ; Humans ; Pancreas ; Purines ; Pyrazoles ; SARS-CoV-2 ; Sulfonamides
Chemical Substances	Azetidines ; Purines ; Pyrazoles ; Sulfonamides ; baricitinib (ISP4442I3Y)
Keywords	covid19
Language	English
Publishing date	2021-02-06
Publishing country	United States
Document type	Letter ; Comment
ZDB-ID	1099781-7
ISSN	1537-6591 ; 1058-4838
ISSN (online)	1537-6591
ISSN	1058-4838
DOI	10.1093/cid/ciaa1209
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1505: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 480: Show issues

Order via subito

Details ▾

Article: Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave.

Guzmán-López, Santos / Darwich-Salazar, Armine / Bocanegra-Ibarias, Paola / Salas-Treviño, Daniel / Flores-Treviño, Samantha / Pérez-Alba, Eduardo / Nuzzolo-Shihadeh, Laura M / Pérez-Rodríguez, Edelmiro / Camacho-Ortiz, Adrián

Vaccines

2022 Volume 10, Issue 5

Abstract: Information regarding the efficacy of the recombinant adenovirus type-5-vectored (CanSino Bio) vaccine against the COVID-19 disease in a real-life setting is limited. A retrospective cohort study was carried out in the teaching university community of ... ...

Abstract	Information regarding the efficacy of the recombinant adenovirus type-5-vectored (CanSino Bio) vaccine against the COVID-19 disease in a real-life setting is limited. A retrospective cohort study was carried out in the teaching university community of the metropolitan area of Monterrey, Mexico, through a four-section survey, and during the COVID-19 delta wave. Determination of IgG antibodies against SARS-CoV-2 spike (S) protein was performed in a subset of participants vaccinated with CanSino Bio. A total of 7468 teachers responded to the survey, and 6695 of them were fully vaccinated. Of those, 72.7% had CanSino Bio, 10.3% Pfizer, 8.4% AstraZeneca, 1.2% Moderna, and 2.7% others. Symptomatic breakthrough infections were recorded in those vaccinated with CanSino Bio (4.1%), AstraZeneca (2.1%), and Pfizer (2.2%). No difference was found between CanSino Bio and other vaccines regarding hospitalization, the need for mechanical ventilation, and death. For CanSino Bio recipients, anti-S antibodies were >50 AU/mL in 73.2%. In conclusion, primary breakthrough symptomatic infections were higher in the CanSino vaccinated group compared to other brands. Individuals with a previous infection had higher antibody levels than those who were reinfected and without infection. A boosted dose of CanSino is recommended for those individuals without a previous infection.
Language	English
Publishing date	2022-04-21
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2703319-3
ISSN	2076-393X
ISSN	2076-393X
DOI	10.3390/vaccines10050656
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico.

Galán-Huerta, Kame A / Flores-Treviño, Samantha / Salas-Treviño, Daniel / Bocanegra-Ibarias, Paola / Rivas-Estilla, Ana M / Pérez-Alba, Eduardo / Lozano-Sepúlveda, Sonia A / Arellanos-Soto, Daniel / Camacho-Ortiz, Adrián

Viruses

2022 Volume 14, Issue 1

Abstract: SARS-CoV-2 variants of concern (VOCs) or of interest (VOIs) causing vaccine breakthrough infections pose an increased risk to worldwide public health. An observational case-control study was performed of SARS-CoV-2 vaccine breakthrough infections in ... ...

Abstract	SARS-CoV-2 variants of concern (VOCs) or of interest (VOIs) causing vaccine breakthrough infections pose an increased risk to worldwide public health. An observational case-control study was performed of SARS-CoV-2 vaccine breakthrough infections in hospitalized or ambulatory patients in Monterrey, Mexico, from April through August 2021. Vaccination breakthrough was defined as a SARS-CoV-2 infection that occurred any time after 7 days of inoculation with partial (e.g., first dose of two-dose vaccines) or complete immunization (e.g., second dose of two-dose vaccines or single-dose vaccine, accordingly). Case group patients (
MeSH term(s)	Adult ; Aged ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Vaccines ; Case-Control Studies ; Female ; Hospitalization ; Hospitals, University ; Humans ; Male ; Mexico/epidemiology ; Middle Aged ; Phylogeny ; Prevalence ; SARS-CoV-2/classification ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Vaccination ; Vaccine Efficacy ; Whole Genome Sequencing
Chemical Substances	COVID-19 Vaccines
Language	English
Publishing date	2022-01-14
Publishing country	Switzerland
Document type	Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
ZDB-ID	2516098-9
ISSN	1999-4915 ; 1999-4915
ISSN (online)	1999-4915
ISSN	1999-4915
DOI	10.3390/v14010154
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Rapid effect of fecal transplantation on C. difficile colitis.

Pérez-Alba, Eduardo / Ortíz-Meza, Itzel Araceli / Flores-Gutiérrez, Juan Pablo / Scharrer, Susanna / Alfaro-Rivera, Christian Gerardo / Camacho-Ortiz, Adrián

Clinics and research in hepatology and gastroenterology

2020 Volume 44, Issue 6, Page(s) e152–e153

MeSH term(s)	Clostridioides difficile ; Duodenal Ulcer/pathology ; Enterocolitis, Pseudomembranous/therapy ; Fatal Outcome ; Fecal Incontinence/etiology ; Fecal Incontinence/therapy ; Fecal Microbiota Transplantation ; Female ; Gastrointestinal Hemorrhage/etiology ; Humans ; Hypotension/etiology ; Hypotension/therapy ; Leukocytosis/etiology ; Leukocytosis/therapy ; Middle Aged ; Shock/etiology
Language	English
Publishing date	2020-03-12
Publishing country	France
Document type	Case Reports ; Letter
ZDB-ID	2594333-9
ISSN	2210-741X ; 2210-7401
ISSN (online)	2210-741X
ISSN	2210-7401
DOI	10.1016/j.clinre.2020.02.001
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Use of self-administered surveys through QR code and same center telemedicine in a walk-in clinic in the era of COVID-19.

Perez-Alba, Eduardo / Nuzzolo-Shihadeh, Laura / Espinosa-Mora, Jaime Eugenio / Camacho-Ortiz, Adrián

Journal of the American Medical Informatics Association : JAMIA

2020 Volume 27, Issue 6, Page(s) 985–986

MeSH term(s)	Ambulatory Care Facilities ; Betacoronavirus ; COVID-19 ; Computer Security ; Coronavirus Infections ; Humans ; Mexico ; Mobile Applications ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; Self Report ; Smartphone ; Software ; Surveys and Questionnaires ; Telemedicine
Keywords	covid19
Language	English
Publishing date	2020-04-10
Publishing country	England
Document type	Letter
ZDB-ID	1205156-1
ISSN	1527-974X ; 1067-5027
ISSN (online)	1527-974X
ISSN	1067-5027
DOI	10.1093/jamia/ocaa054
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4128: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 312: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis.

Pérez-Alba, Eduardo / Nuzzolo-Shihadeh, Laura / Aguirre-García, Gloria Mayela / Espinosa-Mora, Jaime / Lecona-Garcia, Juan Diego / Flores-Pérez, Romulo Omar / Mendoza-Garza, Marisela / Camacho-Ortiz, Adrián

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

2021 Volume 54, Issue 5, Page(s) 787–793

Abstract: Objective: We aimed to analyze clinical outcomes from patients with severe COVID-19 pneumonia that received either baricitinib plus dexamethasone or dexamethasone monotherapy.: Methodology: We performed a retrospective comparative study. Data from ... ...

Abstract	Objective: We aimed to analyze clinical outcomes from patients with severe COVID-19 pneumonia that received either baricitinib plus dexamethasone or dexamethasone monotherapy. Methodology: We performed a retrospective comparative study. Data from hospitalized patients with severe COVID-19 pneumonia (saturation <93%, bilateral pulmonary infiltrates) that were treated with baricitinib plus dexamethasone or dexamethasone were collected. Our primary objective was to compare overall mortality and secondly to compare progression to mechanical ventilation and over infection rates. Results: A total of 793 patients were assessed for inclusion criteria, 596 were excluded and 197 were analyzed for primary outcome: 123 in the baricitinib plus dexamethasone group and 74 in the dexamethasone monotherapy group. The mean age was 59.9 years (SD ± 14.5) and 62.1% (123/197) were male. 42.9% (85/197) of the cases required ICU admission and 25.8% (51/197) underwent invasive mechanical ventilation (IMV). Overall thirty-day mortality was 27.9% (55/197); Mortality was significantly lower in the baricitinib plus dexamethasone group compared to the dexamethasone monotherapy group (20.3% vs 40.5%, P = <.05). There was no difference in hospital acquired infections between both groups. Conclusion: Thirty-day mortality was significantly lower in patients with COVID-19 pneumonia treated with baricitinib plus dexamethasone versus dexamethasone monotherapy. No difference was observed in progression to invasive mechanical ventilation and hospital acquired infections.
MeSH term(s)	Aged ; Azetidines/therapeutic use ; Dexamethasone/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Retrospective Studies ; SARS-CoV-2/drug effects ; Sulfonamides/therapeutic use ; COVID-19 Drug Treatment
Chemical Substances	Azetidines ; Purines ; Pyrazoles ; Sulfonamides ; Dexamethasone (7S5I7G3JQL) ; baricitinib (ISP4442I3Y)
Language	English
Publishing date	2021-07-03
Publishing country	England
Document type	Journal Article
ZDB-ID	1497590-7
ISSN	1995-9133 ; 1684-1182 ; 0253-2662
ISSN (online)	1995-9133
ISSN	1684-1182 ; 0253-2662
DOI	10.1016/j.jmii.2021.05.009
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 2083: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Book ; Online: Jornada del cálculo de la huella hídrica como una estrategia de educación ambiental en la universidad Santiago de Cali

Quijano Pérez, Silvia Andrea / Guevara Fletcher, Carlos Eduardo / Vera Lizcano, Omaira / Cerón Hernández, Víctor Alfonso / Bermúdez Vera, Iván Mauricio / Panesso Guevara, Madelen / Olaya Garcerá, Jorge Eliecer / Caro Ruiz, Flor Alba / Rojas Muñoz, Alfonso Lucas / Caro Ruiz, Flor Alba

2020

Keywords	Business innovation ; Huella hídrica ; Ahorro de agua ; Comunidad ; Sensibilización ; Universidad Santiago de Cali
Language	0\|s
Size	1 electronic resource (157-170 pages)
Publisher	Universidad Santiago de Cali
Publishing place	Colombia
Document type	Book ; Online
Note	Spanish ; Open Access
HBZ-ID	HT021618671
ISBN	978-958-5147-13-3 ; 958-5147-13-0
Database	ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave

Santos Guzmán-López / Armine Darwich-Salazar / Paola Bocanegra-Ibarias / Daniel Salas-Treviño / Samantha Flores-Treviño / Eduardo Pérez-Alba / Laura M. Nuzzolo-Shihadeh / Edelmiro Pérez-Rodríguez / Adrián Camacho-Ortiz

Vaccines, Vol 10, Iss 656, p

2022 Volume 656

Abstract	Information regarding the efficacy of the recombinant adenovirus type-5-vectored (CanSino Bio) vaccine against the COVID-19 disease in a real-life setting is limited. A retrospective cohort study was carried out in the teaching university community of the metropolitan area of Monterrey, Mexico, through a four-section survey, and during the COVID-19 delta wave. Determination of IgG antibodies against SARS-CoV-2 spike (S) protein was performed in a subset of participants vaccinated with CanSino Bio. A total of 7468 teachers responded to the survey, and 6695 of them were fully vaccinated. Of those, 72.7% had CanSino Bio, 10.3% Pfizer, 8.4% AstraZeneca, 1.2% Moderna, and 2.7% others. Symptomatic breakthrough infections were recorded in those vaccinated with CanSino Bio (4.1%), AstraZeneca (2.1%), and Pfizer (2.2%). No difference was found between CanSino Bio and other vaccines regarding hospitalization, the need for mechanical ventilation, and death. For CanSino Bio recipients, anti-S antibodies were >50 AU/mL in 73.2%. In conclusion, primary breakthrough symptomatic infections were higher in the CanSino vaccinated group compared to other brands. Individuals with a previous infection had higher antibody levels than those who were reinfected and without infection. A boosted dose of CanSino is recommended for those individuals without a previous infection.
Keywords	COVID 19 ; vaccine ; SARS-CoV-2 ; immunity ; adenovirus vector vaccine ; Medicine ; R
Language	English
Publishing date	2022-04-01T00:00:00Z
Publisher	MDPI AG
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED